Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
ASCO Annual meetingASCO Annual meeting
Not Confirmed
Not Confirmed
29 May-02 June, 2026
Not Confirmed
Not Confirmed
01-03 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
ASCO Annual meetingASCO Annual meeting
Industry Trade Show
Not Confirmed
29 May-02 June, 2026
Industry Trade Show
Not Confirmed
01-03 June, 2026
Digital content

13 Apr 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/abcam-launches-simplestep-ignite-elisa-an-innovative-assay-platform-that-combines-50x-higher-sensitivity-and-up-to-35x-wider-dynamic-range-in-only-55-minutes-302739929.html

20 Jan 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/abcam-joins-the-innovative-health-initiative-ligand-ai-project-to-advance-artificial-intelligence-ai-driven-drug-discovery-through-open-science-302665355.html

14 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/citeab-reveals-the-top-100-cited-ruo-antibodies-highlighting-antibody-market-leaders-and-emerging-research-trends-302582998.html

07 Dec 2023
// Khushi Mandowara REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/danaher-completes-57-billion-acquisition-abcam-2023-12-06/

07 Nov 2023
// PRESS RELEASE
https://corporate.abcam.com/shareholders-of-abcam-approve-proposed-acquisition-by-danaher/

23 Oct 2023
// BUSINESSWIRE
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Under the terms of the agreement, Twist Bioscience grants Abcam the right to engage in research and development activities using Twist single domain (VHH) synthetic antibody library.
Lead Product(s): Undisclosed
Therapeutic Area: Technology Brand Name: Undisclosed
Study Phase: DiscoveryProduct Type: Undisclosed
Recipient: Twist Bioscience
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration February 01, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery
Recipient : Twist Bioscience
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the terms of the agreement, Twist Bioscience grants Abcam the right to engage in research and development activities using Twist single domain (VHH) synthetic antibody library.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
February 01, 2022

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE